Role for myosin-V motor proteins in the selective delivery of Kv channel isoforms to the membrane surface of cardiac myocytes

Circulation Research

Volumn 114, Issue 6, 2014, Pages 982-992

  Schumacher Bass, Sarah M ^a   Vesely, Eileen D ^a   Zhang, Lian ^a   Ryland, Katherine E ^a   McEwen, Dyke P ^a   Chan, Priscilla J ^b   Frasier, Chad R ^a   McIntyre, Jeremy C ^a   Shaw, Robin M ^c   Martens, Jeffrey R ^a,d  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c CEDARS SINAI MEDICAL CENTER   (United States)

^d UNIVERSITY OF FLORIDA   (United States)

Author keywords

arrhythmias; cardiac; connexin 43; heart; Kv1.5 potassium channel

Indexed keywords

CONNEXIN 43; MYOSIN V; MYOSIN VA; MYOSIN VB; PHALLOIDIN; POTASSIUM CHANNEL KV1.5; SHORT HAIRPIN RNA; UNCLASSIFIED DRUG;

ADULT; ANIMAL CELL; ARTICLE; CELL DENSITY; CELL LABELING; CELL MIGRATION; CELL MOTILITY; CELL SURFACE; CELL VACUOLE; CONTROLLED STUDY; GENE SILENCING; HEART MUSCLE CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RETROSPECTIVE STUDY; WESTERN BLOTTING;

ARRHYTHMIAS, CARDIAC; CONNEXIN 43; HEART; KV1.5 POTASSIUM CHANNEL;

ACTIN CYTOSKELETON; ANIMALS; ARRHYTHMIAS, CARDIAC; CELL LINE; CELL MEMBRANE; CONNEXIN 43; ENDOCYTOSIS; ETHER-A-GO-GO POTASSIUM CHANNELS; GAP JUNCTIONS; GENES, REPORTER; HEART CONDUCTION SYSTEM; ION TRANSPORT; KV1.5 POTASSIUM CHANNEL; MALE; MEMBRANE POTENTIALS; MICE; MICE, INBRED C57BL; MODELS, CARDIOVASCULAR; MYOCYTES, CARDIAC; MYOSIN HEAVY CHAINS; MYOSIN TYPE V; MYOSINS; POTASSIUM; PROTEIN ISOFORMS; PROTEIN TRANSPORT; RAB GTP-BINDING PROTEINS; RATS; RATS, SPRAGUE-DAWLEY; RECOMBINANT FUSION PROTEINS; RNA INTERFERENCE; RNA, SMALL INTERFERING;

EID: 84897097835     PISSN: 00097330     EISSN: 15244571     Source Type: Journal    
DOI: 10.1161/CIRCRESAHA.114.302711     Document Type: Article

References (68)

1. Amos GJ, Wettwer E, Metzger F, Li Q, Himmel HM, Ravens U. Differences between outward currents of human atrial and subepicardial ventricular myocytes. J Physiol. 1996;491(Pt 1):31-50.
2. Camm AJ. Safety considerations in the pharmacological management of atrial fbrillation. Int J Cardiol. 2008;127:299-306.
3. Camm AJ, Savelieva I. Advances in antiarrhythmic drug treatment of atrial fbrillation: where do we stand now? Heart Rhythm. 2004;1:244-246.
4. Mays DJ, Foose JM, Philipson LH, Tamkun MM. Localization of the Kv1.5 K+ channel protein in explanted cardiac tissue. J Clin Invest. 1995;96:282-292.
5. Lafuente-Lafuente C, Mouly S, Longas-Tejero MA, Bergmann JF. Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fbrillation. Cochrane Database Syst Rev. 2007:CD005049.
6. Lafuente-Lafuente C, Mouly S, Longás-Tejero MA, Mahé I, Bergmann JF. Antiarrhythmic drugs for maintaining sinus rhythm after cardioversion of atrial fbrillation: a systematic review of randomized controlled trials. Arch Intern Med. 2006;166:719-728.
7. Feng J, Wible B, Li GR, Wang Z, Nattel S. Antisense oligodeoxynucleo- tides directed against Kv1.5 mRNA specifcally inhibit ultrarapid delayed rectifer K+ current in cultured adult human atrial myocytes. Circ Res. 1997;80:572-579.
8. Olson TM, Alekseev AE, Liu XK, Park S, Zingman LV, Bienengraeber M, Sattiraju S, Ballew JD, Jahangir A, Terzic A. Kv1.5 channelopathy due to KCNA5 loss-of-function mutation causes human atrial fbrillation. Hum Mol Genet. 2006;15:2185-2191.
9. Tanabe Y, Hatada K, Naito N, Aizawa Y, Chinushi M, Nawa H, Aizawa Y. Over-expression of Kv1.5 in rat cardiomyocytes extremely shortens the duration of the action potential and causes rapid excitation. Biochem Biophys Res Commun. 2006;345:1116-1121.
10. Van Wagoner DR, Pond AL, McCarthy PM, Trimmer JS, Nerbonne JM. Outward K+ current densities and Kv1.5 expression are reduced in chronic human atrial fbrillation. Circ Res. 1997;80:772-781.
11. Ford JW, Milnes JT. New drugs targeting the cardiac ultra-rapid delayed-rectifer current (I Kur): rationale, pharmacology and evidence for potential therapeutic value. J Cardiovasc Pharmacol. 2008;52:105-120.
12. Schumacher SM, McEwen DP, Zhang L, Arendt KL, Van Genderen KM, Martens JR. Antiarrhythmic drug-induced internalization of the atrial-specifc k+ channel kv1.5. Circ Res. 2009;104:1390-1398.
13. Christ T, Wettwer E, Voigt N, Hála O, Radicke S, Matschke K, Várro A, Dobrev D, Ravens U. Pathology-specifc effects of the IKur/Ito/IK, ACh blocker AVE0118 on ion channels in human chronic atrial fbrillation. Br J Pharmacol. 2008;154:1619-1630.
14. Allessie MA, Boyden PA, Camm AJ, Kléber AG, Lab MJ, Legato MJ, Rosen MR, Schwartz PJ, Spooner PM, Van Wagoner DR, Waldo AL. Pathophysiology and prevention of atrial fbrillation. Circulation. 2001;103:769-777.
15. Ausma J, Litjens N, Lenders MH, Duimel H, Mast F, Wouters L, Ramaekers F, Allessie M, Borgers M. Time course of atrial fbrillation-induced cellular structural remodeling in atria of the goat. J Mol Cell Cardiol. 2001;33:2083-2094.
16. Thijssen VL, Ausma J, Liu GS, Allessie MA, van Eys GJ, Borgers M. Structural changes of atrial myocardium during chronic atrial fbrillation. Cardiovasc Pathol. 2000;9:17-28.
17. Goette A, Honeycutt C, Langberg JJ. Electrical remodeling in atrial fbril-lation. Time course and mechanisms. Circulation. 1996;94:2968-2974.
18. Desnos C, Huet S, Darchen F. 'Should I stay or should I go?': myosin V function in organelle traffcking. Biol Cell. 2007;99:411-423.
19. Huang JD, Brady ST, Richards BW, Stenolen D, Resau JH, Copeland NG, Jenkins NA. Direct interaction of microtubule-and actin-based transport motors. Nature. 1999;397:267-270.
20. Langford GM. Myosin-V, a versatile motor for short-range vesicle transport. Traffc. 2002;3:859-865.
21. Brown SS. Cooperation between microtubule-and actin-based motor proteins. Annu Rev Cell Dev Biol. 1999;15:63-80.
22. Hirokawa N. Kinesin and dynein superfamily proteins and the mechanism of organelle transport. Science. 1998;279:519-526.
23. Cai D, McEwen DP, Martens JR, Meyhofer E, Verhey KJ. Single molecule imaging reveals differences in microtubule track selection between Kinesin motors. PLoS Biol. 2009;7:e1000216.
24. Zadeh AD, Cheng Y, Xu H, Wong N, Wang Z, Goonasekara C, Steele DF, Fedida D. Kif5b is an essential forward traffcking motor for the Kv1.5 cardiac potassium channel. J Physiol. 2009;587:4565-4574.
25. Choi WS, Khurana A, Mathur R, Viswanathan V, Steele DF, Fedida D. Kv1.5 surface expression is modulated by retrograde traffcking of newly endocytosed channels by the dynein motor. Circ Res. 2005;97:363-371.
26. McEwen DP, Schumacher SM, Li Q, Benson MD, Iñiguez-Lluhí JA, Van Genderen KM, Martens JR. Rab-GTPase-dependent endocytic recycling of Kv1.5 in atrial myocytes. J Biol Chem. 2007;282:29612-29620.
27. Mason HS, Latten MJ, Godoy LD, Horowitz B, Kenyon JL. Modulation of Kv1.5 currents by protein kinase A, tyrosine kinase, and protein ty-rosine phosphatase requires an intact cytoskeleton. Mol Pharmacol. 2002;61:285-293.
28. Martens JR, Navarro-Polanco R, Coppock EA, Nishiyama A, Parshley L, Grobaski TD, Tamkun MM. Differential targeting of Shaker-like potassium channels to lipid rafts. J Biol Chem. 2000;275:7443-7446.
29. Maruoka ND, Steele DF, Au BP, Dan P, Zhang X, Moore ED, Fedida D. alpha-actinin-2 couples to cardiac Kv1.5 channels, regulating current density and channel localization in HEK cells. FEBS Lett. 2000;473:188-194.
30. Eldstrom J, Choi WS, Steele DF, Fedida D. SAP97 increases Kv1.5 currents through an indirect N-terminal mechanism. FEBS Lett. 2003;547:205-211.
31. Eldstrom J, Doerksen KW, Steele DF, Fedida D. N-terminal PDZ-binding domain in Kv1 potassium channels. FEBS Lett. 2002;531:529-537.
32. Murata M, Buckett PD, Zhou J, Brunner M, Folco E, Koren G. SAP97 interacts with Kv1.5 in heterologous expression systems. Am J Physiol Heart Circ Physiol. 2001;281:H2575-H2584.
33. Cukovic D, Lu GW, Wible B, Steele DF, Fedida D. A discrete amino terminal domain of Kv1.5 and Kv1.4 potassium channels interacts with the spectrin repeats of alpha-actinin-2. FEBS Lett. 2001;498:87-92.
34. Cheng L, Yung A, Covarrubias M, Radice GL. Cortactin is required for N-cadherin regulation of Kv1.5 channel function. J Biol Chem. 2011;286:20478-20489.
35. Smyth JW, Hong TT, Gao D, Vogan JM, Jensen BC, Fong TS, Simpson PC, Stainier DY, Chi NC, Shaw RM. Limited forward traffcking of con-nexin 43 reduces cell-cell coupling in stressed human and mouse myocardium. J Clin Invest. 2010;120:266-279.
36. Smyth JW, Vogan JM, Buch PJ, Zhang SS, Fong TS, Hong TT, Shaw RM. Actin cytoskeleton rest stops regulate anterograde traffc of connexin 43 vesicles to the plasma membrane. Circ Res. 2012;110:978-989.
37. Abi-Char J, El-Haou S, Balse E, Neyroud N, Vranckx R, Coulombe A, Hatem SN. The anchoring protein SAP97 retains Kv1.5 channels in the plasma membrane of cardiac myocytes. Am J Physiol Heart Circ Physiol. 2008;294:H1851-H1861.
38. Dantzig JA, Liu TY, Goldman YE. Functional studies of individual myosin molecules. Ann N Y Acad Sci. 2006;1080:1-18.
39. Zhao L P, Koslovsky JS, Reinhard J, Bähler M, Witt AE, Provance DW Jr, Mercer JA. Cloning and characterization of myr 6, an unconventional myosin of the dilute/myosin-V family. Proc Natl Acad Sci USA. 1996;93:10826-10831.
40. Thibodeau IL, Xu J, Li Q, Liu G, Lam K, Veinot JP, Birnie DH, Jones DL, Krahn AD, Lemery R, Nicholson BJ, Gollob MH. Paradigm of genetic mosaicism and lone atrial fbrillation: physiological characterization of a connexin 43-deletion mutant identifed from atrial tissue. Circulation. 2010;122:236-244.
41. Smyth JW, Shaw RM. Autoregulation of connexin43 gap junction formation by internally translated isoforms. Cell Rep. 2013;5:611-618.
42. Pierobon P, Achouri S, Courty S, Dunn AR, Spudich JA, Dahan M, Cappello G. Velocity, processivity, and individual steps of single myosin V molecules in live cells. Biophys J. 2009;96:4268-4275.
43. Yildiz A, Forkey JN, McKinney SA, Ha T, Goldman YE, Selvin PR. Myosin V walks hand-over-hand: single fuorophore imaging with 1.5-nm localization. Science. 2003;300:2061-2065.
44. Mehta AD, Rock RS, Rief M, Spudich JA, Mooseker MS, Cheney RE. Myosin-V is a processive actin-based motor. Nature. 1999;400:590-593.
45. Vale RD, Milligan RA. The way things move: looking under the hood of molecular motor proteins. Science. 2000;288:88-95.
46. Baker JE, Krementsova EB, Kennedy GG, Armstrong A, Trybus KM, Warshaw DM. Myosin V processivity: multiple kinetic pathways for head-to-head coordination. Proc Natl Acad Sci USA. 2004;101:5542-5546.
47. Song BD, Leonard M, Schmid SL. Dynamin GTPase domain mutants that differentially affect GTP binding, GTP hydrolysis, and clathrin-mediated endocytosis. J Biol Chem. 2004;279:40431-40436.
48. Ullrich O, Reinsch S, Urbé S, Zerial M, Parton RG. Rab11 regulates recycling through the pericentriolar recycling endosome. J Cell Biol. 1996;135:913-924.
49. Ren M, Xu G, Zeng J, De Lemos-Chiarandini C, Adesnik M, Sabatini DD. Hydrolysis of GTP on rab11 is required for the direct delivery of transferrin from the pericentriolar recycling compartment to the cell surface but not from sorting endosomes. Proc Natl Acad Sci USA. 1998;95:6187-6192.
50. Swiatecka-Urban A, Talebian L, Kanno E, Moreau-Marquis S, Coutermarsh B, Hansen K, Karlson KH, Barnaby R, Cheney RE, Langford GM, Fukuda M, Stanton BA. Myosin Vb is required for traffcking of the cystic fbrosis transmembrane conductance regulator in Rab11a-specifc apical recycling endosomes in polarized human airway epithelial cells. J Biol Chem. 2007;282:23725-23736.
51. Treharne KJ, Crawford RM, Mehta A. CFTR, chloride concentration and cell volume: could mammalian protein histidine phosphorylation play a latent role? Exp Physiol. 2006;91:131-139.
52. Wang Z, Edwards JG, Riley N, Provance DW Jr, Karcher R, Li XD, Davison IG, Ikebe M, Mercer JA, Kauer JA, Ehlers MD. Myosin Vb mobilizes recycling endosomes and AMPA receptors for postsynaptic plasticity. Cell. 2008;135:535-548.
53. Roland JT, Bryant DM, Datta A, Itzen A, Mostov KE, Goldenring JR. Rab GTPase-Myo5B complexes control membrane recycling and epithelial polarization. Proc Natl Acad Sci USA. 2011;108:2789-2794.
54. Loewen ME, Wang Z, Eldstrom J, Dehghani Zadeh A, Khurana A, Steele DF, Fedida D. Shared requirement for dynein function and intact micro-tubule cytoskeleton for normal surface expression of cardiac potassium channels. Am J Physiol Heart Circ Physiol. 2009;296:H71-H83.
55. Steele DF, Eldstrom J, Fedida D. Mechanisms of cardiac potassium channel traffcking. J Physiol. 2007;582:17-26.
56. Tiffany AM, Manganas LN, Kim E, Hsueh YP, Sheng M, Trimmer JS. PSD-95 and SAP97 exhibit distinct mechanisms for regulating K(+) channel surface expression and clustering. J Cell Biol. 2000;148:147-158.
57. Leonoudakis D, Conti LR, Radeke CM, McGuire LM, Vandenberg CA. A multiprotein traffcking complex composed of SAP97, CASK, Veli, and Mint1 is associated with inward rectifer Kir2 potassium channels. J Biol Chem. 2004;279:19051-19063.
58. Petrecca K, Miller DM, Shrier A. Localization and enhanced current density of the Kv4.2 potassium channel by interaction with the actin-binding protein flamin. J Neurosci. 2000;20:8736-8744.
59. Hattan D, Nesti E, Cachero TG, Morielli AD. Tyrosine phosphorylation of Kv1.2 modulates its interaction with the actin-binding protein cortactin. J Biol Chem. 2002;277:38596-38606.
60. Shaw RM, Fay AJ, Puthenveedu MA, von Zastrow M, Jan YN, Jan LY. Microtubule plus-end-tracking proteins target gap junctions directly from the cell interior to adherens junctions. Cell. 2007;128:547-560.
61. Brundel BJ, Henning RH, Kampinga HH, Van Gelder IC, Crijns HJ. Molecular mechanisms of remodeling in human atrial fbrillation. Cardiovasc Res. 2002;54:315-324.
62. Brundel BJ, Ausma J, van Gelder IC, Van der Want JJ, van Gilst WH, Crijns HJ, Henning RH. Activation of proteolysis by calpains and structural changes in human paroxysmal and persistent atrial fbrillation. Cardiovasc Res. 2002;54:380-389.
63. Brundel BJ, Kampinga HH, Henning RH. Calpain inhibition prevents pacing-induced cellular remodeling in a HL-1 myocyte model for atrial fbrillation. Cardiovasc Res. 2004;62:521-528.
64. Schäfer AE, Friedl R, Hekmat K, Hannekum A, Kirmanoglou K. Chronic atrial fbrillation: decreased actin expression in patients with chronic atrial fbrillation. J Cardiovasc Surg (Torino). 2008;49:83-86.
65. Van Eyk JE, Powers F, Law W, Larue C, Hodges RS, Solaro RJ. Breakdown and release of myoflament proteins during ischemia and ischemia/reper-fusion in rat hearts: identifcation of degradation products and effects on the pCa-force relation. Circ Res. 1998;82:261-271.
66. Matsumura Y, Saeki E, Inoue M, Hori M, Kamada T, Kusuoka H. Inhomogeneous disappearance of myoflament-related cyto-skeletal proteins in stunned myocardium of guinea pig. Circ Res. 1996;79:447-454.
67. Goll DE, Dayton WR, Singh I, Robson RM. Studies of the alpha-actinin/actin interaction in the Z-disk by using calpain. J Biol Chem. 1991;266:8501-8510.
68. Barta J, Tóth A, Edes I, Vaszily M, Papp JG, Varró A, Papp Z. Calpain-1-sensitive myofbrillar proteins of the human myocardium. Mol Cell Biochem. 2005;278:1-8.